PureTech Health PLC 2024 Annual Report with Sustainability Disclosures
Company: PureTech Health PLC
Sector: Professional & technical services
Country: United States
Year: 2024
Type: Annual Report with Sustainability Disclosures
Pages: 113
The report describes 2024 as a landmark year, including PureTech's third FDA approval for a therapeutic it invented and major progress in its clinical-stage portfolio. Seaport Therapeutics raised $326 million during the year, supporting the group's hub-and-spoke model. The ESG section reports 56 employees at year-end and detailed global GHG, energy and hazardous-waste metrics, while emphasizing continued ESG oversight by the Board and ESG Committee.
Reporting standards, commitments and assurance details are available with a free account.
Data Services
From bulk PDFs to structured indicators and machine-readable documents.